Skip to main content
. 2006 May 22;103(21):8203–8208. doi: 10.1073/pnas.0602566103

Table 2.

HI serology and survival of chickens before and after challenge

Vaccine group* HI serology before challenge (GMT)
Challenge virus No. of survivors HI serology 14 days after challenge (GMT)
AIV/H7 antigen NDV antigen AIV/H7 antigen NDV antigen
rNDV/F3aa-chimericH7, 1× 8/10 (11) 10/10 (49) vNDV 10/10 9/10 (15) 10/10 (416)
rNDV/F3aa-chimericH7, 1× 7/10 (10) 10/10 (49) HPAIV 9/10 9/9 (2,048) 9/9 (37)
rNDV/F3aa-chimericH7, 2× 8/10 (13) 9/10 (56) vNDV 10/10 7/10 (17) 10/10 (315)
rNDV/F3aa-chimericH7, 2× 5/10 (9) 9/10 (60) HPAIV 9/10 8/8 (955) 8/8 (30)
pNDV, 2× 0/10 10/10 (34) vNDV 10/10 0/10 10/10 (294)
pNDV, 2× 0/10 10/10 (56) HPAIV 0/10 NA NA
Sham, 2× 0/10 0/10 vNDV 0/10 NA NA
Sham, 2× 0/10 0/10 HPAIV 3/10 0/3 0/3

Chickens were vaccinated with rNDV containing the AIV H7 HA gene (rNDV/F3aa-chimericH7), pNDV, or sterile tissue culture fluid (sham), followed by challenge with vNDV and A/Human/Steele/59 (H7N7) HPAI virus (HPAIV). HI serology is shown as no. of chickens with HI-positive serum/no. of chickens vaccinated; values in parentheses are geometric mean titer (GMT). NA, not applicable.

*n = 10 birds per group; 1× = one vaccination; 2× = two vaccinations.